Hutchison China MediTech Limited Net Debt | HCM

Net Debt can be roughly defined as financial liabilities that an entity classifies in the financing section together with the resources available to service those financial liabilities^[1]

Net debt is the obligations that remain after deducting all assets and other liabilities from a company or individual. It represents the sum of debts that an organization or person must repay to their creditors or other parties.

Net debt can include various types of obligations such as loans, borrowings, lease liabilities, or credit card payments. It is important to note that net debt does not include current expenses or obligations such as payroll expenses or current bills.

Assessing net debt is an important financial indicator for evaluating the financial position of a company or individual. If net debt significantly exceeds assets, it may indicate financial difficulties and insolvency. In such cases, the company or individual may face difficulties in meeting their obligations and managing their finances.

Net debt can also be used to compare the financial stability of different companies. The lower the net debt relative to assets, the more stable and financially sound they are considered.

Overall, understanding net debt helps evaluate the financial soundness and ability of a company to meet their obligations. It is an important indicator that assists in making decisions about lending, investments, and financial management.

Annual Net Debt Hutchison China MediTech Limited

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-260 K	-91.6 M	-231 M	-291 M	-	-206 M	-91.1 M	-59.3 M	-	-32.6 M	18.1 M	14.3 M	4.64 M	-23.9 M	-23.7 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
18.1 M	-291 M	-78 M

References

Pizzo, M., Moscariello, N., & Vinciguerra, R. (2015). Market Incentives and Regulators' Activity Shaping Financial Information: An Analysis of the Net Debt Disclosure in Italy. International Journal of Business and Management, 10(1), 1.

Net Debt of other stocks in the Biotechnology industry

Issuer	Net Debt	Price	% 24h	Market Cap	Country
Celsion Corporation CLSN	-7.77 M	-	-6.63 %	$ 13.9 M	USA
FSD Pharma HUGE	-16.8 M	-	5743.5 %	$ 69.7 M	Canada
Synthetic Biologics SYN	-10.8 M	-	1.32 %	$ 16.2 M	USA
Dynavax Technologies Corporation DVAX	-65.3 M	-	-	$ 2.02 B	USA
I-Mab IMAB	-2.1 B	-	-	$ 866 M	China
AgeX Therapeutics AGE	71 K	-	-10.17 %	$ 12.2 K	USA
Alexion Pharmaceuticals, Inc. ALXN	-402 M	-	-	$ 40.3 B	USA
Qilian International Holding Group Limited QLI	-9.5 M	-	-6.08 %	$ 184 M	China
Happiness Biotech Group Limited HAPP	-10.1 M	-	1.35 %	$ 17.8 M	China
Genfit SA GNFT	2.27 M	-	2.54 %	$ 160 B	France
Biophytis SA BPTS	-4.01 M	-	-13.47 %	$ 169 M	France
CureVac N.V. CVAC	-443 M	-	-	$ 867 M	Germany
EyeGate Pharmaceuticals, Inc. EYEG	-824 K	-	-1.52 %	$ 24.7 M	USA
Athira Pharma ATHA	-68.5 M	-	-	$ 269 M	USA
BiondVax Pharmaceuticals Ltd. BVXV	52 M	-	0.74 %	$ 768 M	Israel
Abcam plc ABCM	15.3 M	-	-	$ 4.9 B	Britain
Завод ДИОД DIOD	-48.6 M	-	-	-	Russia
Galera Therapeutics GRTX	-17 M	-	-32.59 %	$ 7.61 M	USA
Midatech Pharma plc MTP	-6.17 M	-	-18.52 %	$ 27.3 M	Britain
Hepion Pharmaceuticals HEPA	-14.6 M	-	-18.79 %	$ 39.3 K	USA
ARCA biopharma ABIO	-45 M	-	1052.0 %	$ 415 M	USA
MorphoSys AG MOR	-146 M	-	2.43 %	$ 254 M	Germany
Codexis CDXS	-7.74 M	$ 1.46	2.82 %	$ 127 M	USA
Ardelyx ARDX	136 M	$ 3.78	1.89 %	$ 911 M	USA
Affimed N.V. AFMD	-31.3 M	-	-34.95 %	$ 21.5 M	Germany
Arcutis Biotherapeutics ARQT	65.3 M	$ 23.9	1.01 %	$ 3.04 B	USA
Assembly Biosciences ASMB	-55.8 M	$ 36.6	1.3 %	$ 410 M	USA
AnPac Bio-Medical Science Co., Ltd. ANPC	5.43 M	-	-1.58 %	$ 28.1 M	China
Celyad Oncology SA CYAD	-12.2 M	-	-	$ 12.5 M	Belgium
Adial Pharmaceuticals ADIL	-3.85 M	$ 7.12	6.91 %	$ 4.76 M	USA
Generation Bio Co. GBIO	17.3 M	-	-	$ 344 M	USA
Akero Therapeutics AKRO	-340 M	-	-	$ 3.67 B	USA
Cyclacel Pharmaceuticals CYCCP	-3.5 M	-	-4.36 %	$ 27 M	USA
Gracell Biotechnologies GRCL	-1.39 B	-	-	$ 3.37 B	China
Axsome Therapeutics AXSM	-205 M	$ 206.68	0.16 %	$ 10.3 B	USA
GlycoMimetics GLYC	-212 M	-	9357.83 %	$ 1.01 B	USA
AnaptysBio ANAB	-224 M	$ 56.8	0.94 %	$ 1.63 B	USA
Aeterna Zentaris AEZS	-5.16 M	-	5.93 %	$ 314 M	Canada
AVROBIO AVRO	-253 M	-	1083.1 %	$ 745 M	USA
BioMarin Pharmaceutical BMRN	-1.3 B	$ 66.53	0.15 %	$ 12.8 B	USA
BeiGene, Ltd. BGNE	-3.56 B	-	0.49 %	$ 251 B	Cayman-islands
AIkido Pharma AIKI	-31.2 M	-	1.93 %	$ 17.4 M	USA
Aeglea BioTherapeutics AGLE	-30.2 M	-	-	$ 1.01 B	USA
Aptose Biosciences APTO	-5.53 M	-	-45.71 %	$ 1.2 M	Canada
Bicycle Therapeutics plc BCYC	-625 M	$ 4.3	1.42 %	$ 298 M	Britain
AlloVir ALVR	-96.6 M	-	4.14 %	$ 49.1 M	USA
ChromaDex Corporation CDXC	-62 M	-	-0.88 %	$ 598 M	USA